The Effects of SGLTi on Diabetic Cardiomyopathy
NCT04200586
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Type2 Diabetes
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG:
Dapagliflozin
Sponsor
The University of Hong Kong